In the United States, they developed a quit smoking pill . It is a treatment that blocks nicotine receptors in the brain. Already two hundred people were tested with good results, and now start testing with three trials with more smokers.

As reported by telephone Clarin Betsy Raymond, a spokesperson for the manufacturer, Pfizer, from headquarters in Groton, United States, the pill is called "varenicline" and works to affect certain brain receptors. The effect is gradual. "It proved successful so far, but hope to confirm with larger trials," added the spokeswoman. He stressed that the company does not yet have the date of the launch of the product after the regulatory authority authorized in each country.
For the company, if the quit smoking pill is really effective (not yet known how long patients should take it) could become a hit as was the drug to treat erectile dysfunction (Viagra).
 

In the race for the search for a cessation of therapy, cigarretes, this company is not alone. A French company, Sanofi-Synthelabo, is testing another drug that also affect the brain's receptors. The latter expects to have results for next year, as reported yesterday by the Wall Street Journal newspaper.
The pill from Pfizer is a modulator of nicotinic receptors that occur in smokers the decrease or disappearance of the desire to smoke. It is administered orally.
The researchers were inspired to develop this into a natural remedy tested by doctors of the former Soviet Union in the 60s, which was derived from a herb. Have already been carried out trials with the drug in the United States, Canada and Europe, where he will continue with more tests.
Sources in the company Pfizer Argentina Clarin reported that this subsidiary has not yet participated in trials with the compound varenicline, "but it is hoped that as the research process forward, also participated in a multicenter clinical study of international investigation" clarification.
"At the moment, he added, in case of a drug investigation, we can not provide more details beyond what is already in the public domain in order to avoid false expectations."
According to the spokesperson for the company in the United States, the clinical trial was conducted and included about 200 people. Half of those who took the pill twice a day left smoking after seven weeks.
Meanwhile, only 19 percent of smokers who received sugar pills could stop smoking. Only 3 percent of those who took another  pill that is also used for depression could become smokers.
So far, experts agree that smoking is hard to get away from addiction to cigarretes. When a person stops smoking, you may suffer insomnia, agitation, palpitations, depression, change of character, desire to smoke, irritability and poor concentration.
According to the Pan American Health Organization (PAHO), the highest rates of consumption of cigarretes in America is recorded in the southern cone countries, particularly in Argentina and Chile: smoke about 45 percent of men and 35 per cent of women. Lowest Republic belongs to countries like Dominica, Guyana and Jamaica, where the prevalence of consumption is less than 17 percent.
The most vulnerable group is teenagers. According to PAHO in the Americas, 70 percent of current smokers started smoking before the age of 18.
To curb the pharmacological and psychological dependency that nicotine causes, treatments that are offered today are based on nicotine patches and / or tablets of bupropion, a mild antidepressant. Experts say that drug treatments for the medical consultation is essential, as these remedies may produce unintended effects. However, so far none of them guarantee success.Whatever the treatment whether it is a quit smoking pill or drug ,it's upto the person making the decision to stop smoking that matters ,good luck with your decisions

Check out my other hubs:

stop smoking drug that actually work

Quit smoking withdrawal symptoms explained

quit smoking medicine which has worked !

Quite smoking right now